231 related articles for article (PubMed ID: 11309462)
1. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.
Papapetropoulos S; Paschalis C; Athanassiadou A; Papadimitriou A; Ellul J; Polymeropoulos MH; Papapetropoulos T
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):662-5. PubMed ID: 11309462
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece.
Papapetropoulos S; Ellul J; Paschalis C; Athanassiadou A; Papadimitriou A; Papapetropoulos T
Eur J Neurol; 2003 May; 10(3):281-6. PubMed ID: 12752402
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation.
Bostantjopoulou S; Katsarou Z; Papadimitriou A; Veletza V; Hatzigeorgiou G; Lees A
Mov Disord; 2001 Nov; 16(6):1007-13. PubMed ID: 11748731
[TBL] [Abstract][Full Text] [Related]
4. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients.
Muñoz E; Oliva R; Obach V; Martí MJ; Pastor P; Ballesta F; Tolosa E
Neurosci Lett; 1997 Oct; 235(1-2):57-60. PubMed ID: 9389595
[TBL] [Abstract][Full Text] [Related]
5. Survival duration of Parkinson's disease patients living in Greece who carry the G209A alpha-synuclein mutation.
Papapetropoulos S; Paschalis C; Ellul J; Papapetropoulos T; Athanassiadou A
Mov Disord; 2002 Jul; 17(4):847-8. PubMed ID: 12210894
[No Abstract] [Full Text] [Related]
6. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
Spira PJ; Sharpe DM; Halliday G; Cavanagh J; Nicholson GA
Ann Neurol; 2001 Mar; 49(3):313-9. PubMed ID: 11261505
[TBL] [Abstract][Full Text] [Related]
7. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease.
Chan P; Tanner CM; Jiang X; Langston JW
Neurology; 1998 Feb; 50(2):513-4. PubMed ID: 9484385
[TBL] [Abstract][Full Text] [Related]
8. The G209A mutation in the alpha-synuclein gene in Brazilian families with Parkinson's disease.
Teive HA; Raskin S; Iwamoto FM; Germiniani FM; Baran MH; Werneck LC; Allan N; Quagliato E; Leroy E; Ide SE; Polymeropoulos MH
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):722-4. PubMed ID: 11593272
[TBL] [Abstract][Full Text] [Related]
9. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
Polymeropoulos MH; Lavedan C; Leroy E; Ide SE; Dehejia A; Dutra A; Pike B; Root H; Rubenstein J; Boyer R; Stenroos ES; Chandrasekharappa S; Athanassiadou A; Papapetropoulos T; Johnson WG; Lazzarini AM; Duvoisin RC; Di Iorio G; Golbe LI; Nussbaum RL
Science; 1997 Jun; 276(5321):2045-7. PubMed ID: 9197268
[TBL] [Abstract][Full Text] [Related]
10. The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.
Vaughan J; Durr A; Tassin J; Bereznai B; Gasser T; Bonifati V; De Michele G; Fabrizio E; Volpe G; Bandmann O; Johnson WG; Golbe LI; Breteler M; Meco G; Agid Y; Brice A; Marsden CD; Wood NW
Ann Neurol; 1998 Aug; 44(2):270-3. PubMed ID: 9708553
[TBL] [Abstract][Full Text] [Related]
11. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
12. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance?
Papadimitriou A; Veletza V; Hadjigeorgiou GM; Patrikiou A; Hirano M; Anastasopoulos I
Neurology; 1999 Feb; 52(3):651-4. PubMed ID: 10025809
[TBL] [Abstract][Full Text] [Related]
13. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.
Warner TT; Schapira AH
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):378-9. PubMed ID: 9728955
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease.
Kobayashi H; Krüger R; Markopoulou K; Wszolek Z; Chase B; Taka H; Mineki R; Murayama K; Riess O; Mizuno Y; Hattori N
Brain; 2003 Jan; 126(Pt 1):32-42. PubMed ID: 12477695
[TBL] [Abstract][Full Text] [Related]
15. [A 73-year-old woman with familial Parkinson's disease].
Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
[TBL] [Abstract][Full Text] [Related]
17. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan.
Izumi Y; Morino H; Oda M; Maruyama H; Udaka F; Kameyama M; Nakamura S; Kawakami H
Neurosci Lett; 2001 Mar; 300(2):125-7. PubMed ID: 11207390
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.
Pastor P; Muñoz E; Ezquerra M; Obach V; Martí MJ; Valldeoriola F; Tolosa E; Oliva R
Mov Disord; 2001 Nov; 16(6):1115-9. PubMed ID: 11748744
[TBL] [Abstract][Full Text] [Related]
19. The alpha-synuclein gene and Parkinson disease in a Chinese population.
Chan DK; Mellick G; Cai H; Wang XL; Ng PW; Pang CP; Woo J; Kay R
Arch Neurol; 2000 Apr; 57(4):501-3. PubMed ID: 10768624
[TBL] [Abstract][Full Text] [Related]
20. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication.
Singleton A; Gwinn-Hardy K; Sharabi Y; Li ST; Holmes C; Dendi R; Hardy J; Singleton A; Crawley A; Goldstein DS
Brain; 2004 Apr; 127(Pt 4):768-72. PubMed ID: 14736756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
